{"DataElement":{"publicId":"2596288","version":"1","preferredName":"Therapeutic Procedure Received Type","preferredDefinition":"the type of the action or administration of therapeutic agents to produce an effect that is intended to alter the course of a pathologic process being received.","longName":"TX_RECVD_TP","context":"CTEP","contextVersion":"2.31","DataElementConcept":{"publicId":"2596286","version":"1","preferredName":"Therapeutic Procedure Received","preferredDefinition":"information related to the action or administration of therapeutic agents to produce an effect that is intended to alter the course of a pathologic process being received.","longName":"TX_RECVD","context":"CTEP","contextVersion":"2.31","ObjectClass":{"publicId":"2512834","version":"1","preferredName":"Therapeutic Procedure","preferredDefinition":"An action or administration of therapeutic agents to produce an effect that is intended to alter the course of a pathologic process.","longName":"C49236","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Therapeutic Procedure","conceptCode":"C49236","definition":"An action or administration of therapeutic agents to produce an effect that is intended to alter or stop a pathologic process.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":"NCI Thesaurus","workflowStatus":"RELEASED","registrationStatus":"Application","id":"1B89860A-B9D6-3798-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2006-08-21","endDate":null,"createdBy":"UMLLOADER_AGNIS","dateCreated":"2006-08-21","modifiedBy":"SBREXT","dateModified":"2007-11-07","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"Property":{"publicId":"2241679","version":"1","preferredName":"Received","preferredDefinition":"Received; taken, gotten, or acquired.","longName":"C25639","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Receive","conceptCode":"C25639","definition":"To take, accept, or get something offered.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":"NCI Thesaurus","workflowStatus":"RELEASED","registrationStatus":"Application","id":"F9FD4EEB-2368-0B27-E034-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2005-07-09","endDate":null,"createdBy":"SHIDED","dateCreated":"2005-07-09","modifiedBy":"ONEDATA","dateModified":"2005-07-09","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ConceptualDomain":{"publicId":"2008538","version":"1","preferredName":"Therapies","preferredDefinition":"actions or administration of therapeutic agents to produce an effect that is intended to alter the course of a pathologic process (NCI).","longName":"TX","context":"CTEP","contextVersion":"2.31","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"B214D04D-9F05-1CA5-E034-0003BA12F5E7","latestVersionIndicator":"Yes","beginDate":"2002-12-18","endDate":null,"createdBy":"MSUPLEY","dateCreated":"2002-12-18","modifiedBy":"SBR","dateModified":"2003-10-29","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"295DA029-4A64-5411-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2007-02-13","endDate":null,"createdBy":"CAMPBELB","dateCreated":"2007-02-13","modifiedBy":"SBR","dateModified":"2016-06-06","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ValueDomain":{"publicId":"2183829","version":"1","preferredName":"Therapy Received Type","preferredDefinition":"the type of therapy received.","longName":"TX_RECD_TP","context":"CTEP","contextVersion":"2.31","type":"Enumerated","dataType":"CHARACTER","minLength":null,"maxLength":"100","minValue":null,"maxValue":null,"decimalPlace":null,"PermissibleValues":[{"value":"Local RT","valueDescription":"Local RT","ValueMeaning":{"publicId":"2569642","version":"1","preferredName":"Local RT","longName":"2569642","preferredDefinition":"Local RT","context":"NCIP","contextVersion":"1","Concepts":[],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2509CE87-DD17-5C23-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2004-05-20","endDate":null,"createdBy":"CAMPBELB","dateCreated":"2004-05-20","modifiedBy":"SBREXT","dateModified":"2007-08-22","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"DADAFAA2-548C-6A13-E034-0003BA12F5E7","beginDate":"2004-05-20","endDate":null,"createdBy":"CAMPBELB","dateCreated":"2004-05-20","modifiedBy":"SBR","dateModified":"2005-03-29","deletedIndicator":"No"},{"value":"Regional RT","valueDescription":"Regional RT","ValueMeaning":{"publicId":"2569643","version":"1","preferredName":"Regional RT","longName":"2569643","preferredDefinition":"Regional RT","context":"NCIP","contextVersion":"1","Concepts":[],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2509CE87-DD18-5C23-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2004-05-20","endDate":null,"createdBy":"CAMPBELB","dateCreated":"2004-05-20","modifiedBy":"SBREXT","dateModified":"2007-08-22","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"DADAFAA2-5490-6A13-E034-0003BA12F5E7","beginDate":"2004-05-20","endDate":null,"createdBy":"CAMPBELB","dateCreated":"2004-05-20","modifiedBy":"SBR","dateModified":"2005-03-29","deletedIndicator":"No"},{"value":"Chest wall RT","valueDescription":"Chest wall RT","ValueMeaning":{"publicId":"2569644","version":"1","preferredName":"Chest wall RT","longName":"2569644","preferredDefinition":"Chest wall RT","context":"NCIP","contextVersion":"1","Concepts":[],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2509CE87-DD19-5C23-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2004-05-20","endDate":null,"createdBy":"CAMPBELB","dateCreated":"2004-05-20","modifiedBy":"SBREXT","dateModified":"2007-08-22","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"DADAFAA2-5494-6A13-E034-0003BA12F5E7","beginDate":"2004-05-20","endDate":null,"createdBy":"CAMPBELB","dateCreated":"2004-05-20","modifiedBy":"SBR","dateModified":"2005-03-29","deletedIndicator":"No"},{"value":"Chemotherapy","valueDescription":"Chemotherapy","ValueMeaning":{"publicId":"2558484","version":"1","preferredName":"Chemotherapy","longName":"2558484","preferredDefinition":"The use of synthetic or naturally-occurring chemicals for the treatment of diseases.  Although this term is used to describe any therapy involving the use of chemical-based agents, it is particularly used to refer to the use of chemical-based agents to treat cancer. Antineoplastic chemotherapy works by arresting or killing the growth and spread of cancer cells. Chemotherapy may also include agents that enhance immune function or alter hormonal activity.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Chemotherapy","conceptCode":"C15632","definition":"The use of synthetic or naturally-occurring chemicals for the treatment of diseases.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2509CE87-B181-5C23-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2002-02-13","endDate":null,"createdBy":"SBR","dateCreated":"2002-02-13","modifiedBy":"COOPERM","dateModified":"2014-12-09","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"295E0ED0-1872-33A1-E044-0003BA3F9857","beginDate":"2007-02-13","endDate":null,"createdBy":"CAMPBELB","dateCreated":"2007-02-13","modifiedBy":"ONEDATA","dateModified":"2007-02-13","deletedIndicator":"No"},{"value":"Hormone Therapy","valueDescription":"Hormone Therapy","ValueMeaning":{"publicId":"2580225","version":"1","preferredName":"Hormone Therapy","longName":"2580225","preferredDefinition":"Various treatment modalities that produce the desired therapeutic effect by means of change of hormone/hormones level. The treatment may include administration of hormones or hormone analogs to the patient, or decreasing the level of hormones in the body by using hormone antagonists, or hormone ablation therapy. The concept covers but not limited to: intermittent or permanent hormone suppression or ablation in treatment of hormone-dependent tumors, hormone replacement therapy of any kind, hormonal component of gender reassignment therapy, hormonal contraception, surgical and radiation castration.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Hormone Therapy","conceptCode":"C15445","definition":"Various treatment modalities that produce the desired therapeutic effect by means of change of hormone/hormones level.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2509CE88-066E-5C23-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2006-07-12","endDate":null,"createdBy":"REEVESD","dateCreated":"2006-07-12","modifiedBy":"ONEDATA","dateModified":"2006-07-12","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"295E0ED0-187D-33A1-E044-0003BA3F9857","beginDate":"2007-02-13","endDate":null,"createdBy":"CAMPBELB","dateCreated":"2007-02-13","modifiedBy":"ONEDATA","dateModified":"2007-02-13","deletedIndicator":"No"},{"value":"No treatment received","valueDescription":"No treatment received","ValueMeaning":{"publicId":"3185669","version":"1","preferredName":"No treatment received","longName":"3185669","preferredDefinition":"No treatment received","context":"NCIP","contextVersion":"1","Concepts":[],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"9A9AF275-7B4F-5E44-E040-BB89AD433FFC","latestVersionIndicator":"Yes","beginDate":"2011-01-24","endDate":null,"createdBy":"SHIDED","dateCreated":"2011-01-24","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"9A9AF275-7B68-5E44-E040-BB89AD433FFC","beginDate":"2011-01-24","endDate":null,"createdBy":"SHIDED","dateCreated":"2011-01-24","modifiedBy":"ONEDATA","dateModified":"2011-01-24","deletedIndicator":"No"},{"value":"SBRT only","valueDescription":"Stereotactic Body Radiation Therapy only","ValueMeaning":{"publicId":"3181460","version":"1","preferredName":"Stereotactic Body Radiation Therapy only","longName":"3181460","preferredDefinition":"Stereotactic Body Radiation Therapy only","context":"NCIP","contextVersion":"1","Concepts":[],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"9932D78C-BAB9-314D-E040-BB89AD433966","latestVersionIndicator":"Yes","beginDate":"2011-01-06","endDate":null,"createdBy":"SHIDED","dateCreated":"2011-01-06","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"9A9AF275-7B72-5E44-E040-BB89AD433FFC","beginDate":"2011-01-24","endDate":null,"createdBy":"SHIDED","dateCreated":"2011-01-24","modifiedBy":"ONEDATA","dateModified":"2011-01-24","deletedIndicator":"No"},{"value":"Surgery without brachytherapy","valueDescription":"Surgery without brachytherapy","ValueMeaning":{"publicId":"3181461","version":"1","preferredName":"Surgery without brachytherapy","longName":"3181461","preferredDefinition":"Surgery without brachytherapy","context":"NCIP","contextVersion":"1","Concepts":[],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"9932D78C-BADC-314D-E040-BB89AD433966","latestVersionIndicator":"Yes","beginDate":"2011-01-06","endDate":null,"createdBy":"SHIDED","dateCreated":"2011-01-06","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"9A9AF275-7B7C-5E44-E040-BB89AD433FFC","beginDate":"2011-01-24","endDate":null,"createdBy":"SHIDED","dateCreated":"2011-01-24","modifiedBy":"ONEDATA","dateModified":"2011-01-24","deletedIndicator":"No"},{"value":"Surgery with brachytherapy","valueDescription":"Surgery with brachytherapy","ValueMeaning":{"publicId":"3181462","version":"1","preferredName":"Surgery with brachytherapy","longName":"3181462","preferredDefinition":"Surgery with brachytherapy","context":"NCIP","contextVersion":"1","Concepts":[],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"9932D78C-BAFF-314D-E040-BB89AD433966","latestVersionIndicator":"Yes","beginDate":"2011-01-06","endDate":null,"createdBy":"SHIDED","dateCreated":"2011-01-06","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"9A9AF275-7B86-5E44-E040-BB89AD433FFC","beginDate":"2011-01-24","endDate":null,"createdBy":"SHIDED","dateCreated":"2011-01-24","modifiedBy":"ONEDATA","dateModified":"2011-01-24","deletedIndicator":"No"},{"value":"Other, specify","valueDescription":"Other, specify","ValueMeaning":{"publicId":"4337194","version":"1","preferredName":"Other, specify","longName":"4337194","preferredDefinition":"Be specific about something; define clearly.: Different than the one(s) previously specified or mentioned.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Specify","conceptCode":"C25685","definition":"Be specific about something; define clearly.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Other","conceptCode":"C17649","definition":"Different than the one(s) previously specified or mentioned.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"FA7C1A6F-1EF3-C2AB-E040-BB89AD436686","latestVersionIndicator":"Yes","beginDate":"2014-05-28","endDate":null,"createdBy":"COOPERM","dateCreated":"2014-05-28","modifiedBy":"KUMMEROA","dateModified":"2023-04-06","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"0FDC9539-B18B-CB07-E050-BB89AD436926","beginDate":"2015-02-24","endDate":null,"createdBy":"TSANE","dateCreated":"2015-02-24","modifiedBy":"ONEDATA","dateModified":"2015-02-24","deletedIndicator":"No"},{"value":"Removal of CSF","valueDescription":"Cerebrospinal Fluid","ValueMeaning":{"publicId":"4363571","version":"1","preferredName":"Cerebrospinal Fluid","longName":"4363571v1.00","preferredDefinition":"The fluid that is contained within the brain ventricles, the subarachnoid space and the central canal of the spinal cord.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Cerebrospinal Fluid","conceptCode":"C12692","definition":"The fluid that is contained within the brain ventricles, the subarachnoid space and the central canal of the spinal cord.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"FC88F450-0E72-248C-E040-BB89AD431A3B","latestVersionIndicator":"Yes","beginDate":"2014-06-23","endDate":null,"createdBy":"MAESKEB","dateCreated":"2014-06-23","modifiedBy":"GDEEN","dateModified":"2023-08-01","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"0FDC9539-B1A0-CB07-E050-BB89AD436926","beginDate":"2015-02-24","endDate":null,"createdBy":"TSANE","dateCreated":"2015-02-24","modifiedBy":"ONEDATA","dateModified":"2015-02-24","deletedIndicator":"No"},{"value":"Discontinued ATRA","valueDescription":"Discontinue Tretinoin","ValueMeaning":{"publicId":"4723859","version":"1","preferredName":"Discontinue Tretinoin","longName":"4723859","preferredDefinition":"To stop or end, permanently or temporarily.: A naturally-occurring acid of retinol. Tretinoin binds to and activates retinoic acid receptors (RARs), thereby inducing changes in gene expression that lead to cell differentiation, decreased cell proliferation, and inhibition of tumorigenesis.  This agent also inhibits telomerase, resulting in telomere shortening and eventual apoptosis of some tumor cell types.  The oral form of tretinoin has teratogenic and embryotoxic properties.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Discontinue","conceptCode":"C25484","definition":"To stop or end, permanently or temporarily.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Tretinoin","conceptCode":"C900","definition":"A naturally-occurring acid of retinol. Tretinoin binds to and activates retinoic acid receptors (RARs), thereby inducing changes in gene expression that lead to cell differentiation, decreased cell proliferation, and inhibition of tumorigenesis.  This agent also inhibits telomerase, resulting in telomere shortening and eventual apoptosis of some tumor cell types.  The oral form of tretinoin has teratogenic and embryotoxic properties.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"0FDC9539-B1AE-CB07-E050-BB89AD436926","latestVersionIndicator":"Yes","beginDate":"2015-02-24","endDate":null,"createdBy":"TSANE","dateCreated":"2015-02-24","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"0FDC9539-B1C7-CB07-E050-BB89AD436926","beginDate":"2015-02-24","endDate":null,"createdBy":"TSANE","dateCreated":"2015-02-24","modifiedBy":"ONEDATA","dateModified":"2015-02-24","deletedIndicator":"No"},{"value":"Analgesics","valueDescription":"Analgesic Agent","ValueMeaning":{"publicId":"4723860","version":"1","preferredName":"Analgesic Agent","longName":"4723860","preferredDefinition":"Drugs that reduce pain. These drugs include aspirin, acetaminophen, and ibuprofen.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Analgesic Agent","conceptCode":"C241","definition":"Compounds that alleviate pain without loss of consciousness.  Analgesics act by various mechanisms including binding with opioid receptors and decreasing inflammation.  Choice of analgesic may be determined by the type of pain.  These compounds include opioid, non-opioid and adjuvant analgesic agents.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"0FDC9539-B1D1-CB07-E050-BB89AD436926","latestVersionIndicator":"Yes","beginDate":"2015-02-24","endDate":null,"createdBy":"TSANE","dateCreated":"2015-02-24","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"0FDC9539-B1EA-CB07-E050-BB89AD436926","beginDate":"2015-02-24","endDate":null,"createdBy":"TSANE","dateCreated":"2015-02-24","modifiedBy":"ONEDATA","dateModified":"2015-02-24","deletedIndicator":"No"},{"value":"Acetazolamide (Diamox)","valueDescription":"Acetazolamide","ValueMeaning":{"publicId":"4723861","version":"1","preferredName":"Acetazolamide","longName":"4723861","preferredDefinition":"A sulfonamide derivative with diuretic, antiglaucoma, and anticonvulsant properties. Acetazolamide is a non-competitive inhibitor of carbonic anhydrase, an enzyme found in cells in the proximal tube of the kidney, the eye, and glial cells. Inhibition of this enzyme in the kidney prevents excretion of hydrogen, leading to increased bicarbonate and cation excretion and increased urinary volume, which results in an alkaline diuresis. Acetazolamide reduces the concentration of bicarbonate, resulting in a decreased synthesis of aqueous humor in the eye, thereby lowering intraocular pressure. Although its mechanism of action is unknown, acetazolamide has anti-convulsant properties resulting from indirect effects secondary to metabolic acidosis or direct effects on neuronal transmission. Acetazolamide also produces respiratory stimulant effects in response to changes to both carbon dioxide and oxygen tension levels within the lungs.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Acetazolamide","conceptCode":"C28809","definition":"A sulfonamide derivative with diuretic, antiglaucoma, and anticonvulsant properties. Acetazolamide is a non-competitive inhibitor of carbonic anhydrase, an enzyme found in cells in the proximal tube of the kidney, the eye, and glial cells. Inhibition of this enzyme in the kidney prevents excretion of hydrogen, leading to increased bicarbonate and cation excretion and increased urinary volume, which results in an alkaline diuresis. Acetazolamide reduces the concentration of bicarbonate, resulting in a decreased synthesis of aqueous humor in the eye, thereby lowering intraocular pressure. Although its mechanism of action is unknown, acetazolamide has anti-convulsant properties resulting from indirect effects secondary to metabolic acidosis or direct effects on neuronal transmission. Acetazolamide also produces respiratory stimulant effects in response to changes to both carbon dioxide and oxygen tension levels within the lungs.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"0FDC9539-B1F4-CB07-E050-BB89AD436926","latestVersionIndicator":"Yes","beginDate":"2015-02-24","endDate":null,"createdBy":"TSANE","dateCreated":"2015-02-24","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"0FDC9539-B20D-CB07-E050-BB89AD436926","beginDate":"2015-02-24","endDate":null,"createdBy":"TSANE","dateCreated":"2015-02-24","modifiedBy":"ONEDATA","dateModified":"2015-02-24","deletedIndicator":"No"}],"ConceptualDomain":{"publicId":"2008538","version":"1","preferredName":"Therapies","preferredDefinition":"actions or administration of therapeutic agents to produce an effect that is intended to alter the course of a pathologic process (NCI).","longName":"TX","context":"CTEP","contextVersion":"2.31","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"B214D04D-9F05-1CA5-E034-0003BA12F5E7","latestVersionIndicator":"Yes","beginDate":"2002-12-18","endDate":null,"createdBy":"MSUPLEY","dateCreated":"2002-12-18","modifiedBy":"SBR","dateModified":"2003-10-29","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"RepresentationTerm":{"publicId":"2177853","version":"1","preferredName":"Type","preferredDefinition":"Type; a subdivision of a particular kind of thing.","longName":"Type","context":"CTEP","contextVersion":"2.31","Concepts":[{"longName":"Type","conceptCode":"C25284","definition":"Something distinguishable as an identifiable class based on common qualities.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"C16D625D-02B6-1907-E034-0003BA12F5E7","latestVersionIndicator":"Yes","beginDate":"2003-07-09","endDate":null,"createdBy":"MSUPLEY","dateCreated":"2003-07-09","modifiedBy":"SBR","dateModified":"2005-09-08","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"DADAF0C1-7A7E-6895-E034-0003BA12F5E7","latestVersionIndicator":"Yes","beginDate":"2004-05-20","endDate":null,"createdBy":"CAMPBELB","dateCreated":"2004-05-20","modifiedBy":"TSANE","dateModified":"2015-02-24","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ClassificationSchemes":[{"publicId":"2008587","version":"2","longName":"Type of Disease","context":"CTEP","ClassificationSchemeItems":[{"publicId":"2811835","version":"1","longName":"Melanoma","context":"CTEP"},{"publicId":"2811871","version":"1","longName":"Colorectal","context":"CTEP"},{"publicId":"2811907","version":"1","longName":"Bladder","context":"CTEP"},{"publicId":"2811908","version":"1","longName":"Gynecologic","context":"CTEP"},{"publicId":"2811909","version":"1","longName":"Leukemia","context":"CTEP"},{"publicId":"2811949","version":"1","longName":"Brain","context":"CTEP"},{"publicId":"2811950","version":"1","longName":"Multiple Myeloma","context":"CTEP"}]},{"publicId":"2008589","version":"2","longName":"Type of Category","context":"CTEP","ClassificationSchemeItems":[{"publicId":"2811963","version":"1","longName":"Treatment","context":"CTEP"}]}],"AlternateNames":[{"name":"SWOG","type":"USED_BY","context":"SWOG"},{"name":"AGENTS","type":"OID, SWOG","context":"SWOG"},{"name":"COG","type":"USED_BY","context":"COG"}],"ReferenceDocuments":[{"name":"After receiving the treatment","type":"Preferred Question Text","description":"After receiving the treatment assignment, indicate which treatment(s) patient has agreed to receive","url":null,"context":"CTEP"},{"name":"CRF Text","type":"Alternate Question Text","description":"Therapy received","url":null,"context":"CTEP"},{"name":"CRF Text1","type":"Alternate Question Text","description":"Which treatment did the patient receive","url":null,"context":"CTEP"},{"name":"List agents received","type":"Alternate Question Text","description":"If yes, please list agents received","url":null,"context":"SWOG"},{"name":"COG CRF TEXT 1","type":"Alternate Question Text","description":"Indicate treatment received:","url":null,"context":"COG"}],"origin":"ECOG CRF:Eastern Cooperative Oncology Group Case Report Form","workflowStatus":"RELEASED","registrationStatus":"Application","id":"295DBE35-D6E4-2E8A-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2007-02-13","endDate":null,"createdBy":"CAMPBELB","dateCreated":"2007-02-13","modifiedBy":"TSANE","dateModified":"2015-02-27","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"}}